Brain Health in 2030: Navigating Neuroplasticity & the Digital Health Market

By SharpBrains | January 23, 2024

Brain Health in 2030: Nav­i­gat­ing Neu­ro­plas­tic­i­ty & the Dig­i­tal Health Mar­ket from Sharp­Brains Keynote deliv­ered by Álvaro Fer­nán­dez, CEO of Sharp­Brains, dur­ing cor­po­rate retreat. Key mes­sage: Our very human brains and minds are the most sophis­ti­cat­ed tech­nol­o­gy at our dis­pos­al, so we should invest more time learn­ing about how they work and har­ness­ing neu­ro­­plas­tic­i­­ty-based methods…

Read More

Without Brain Health, you do not have Health

By Dr. Sandra Bond Chapman | February 10, 2023 |

As you go through life, your brain under­goes extra­or­di­nary devel­op­ment. Your brain is the most adapt­able, mod­i­fi­able organ in your body, and it can change both pos­i­tive­ly and neg­a­tive­ly by how you use it each day. Just by read­ing a book such as this one, your brain has been changed. How has your brain been…

Read More

Building cognitive reserve helps delay memory and thinking decline regardless of genetic or childhood markers

By SharpBrains | August 30, 2022

Wel­come to a new edi­tion of Sharp­Brains’ e‑newsletter, fea­tur­ing time­ly brain news and a few fun brain teasers to test your per­cep­tu­al and cog­ni­tive skills. #1. Study: Build­ing cog­ni­tive reserve helps delay mem­o­ry and think­ing decline regard­less of genet­ic or child­hood mark­ers “While our child­hood can influ­ence our mem­o­ry and think­ing skills lat­er in life,…

Read More

A conversation at the frontier of digital health innovation, FDA regulations, and cognitive health

By SharpBrains | March 23, 2022

Dig­i­tal Ther­a­peu­tics for MCI and Alzheimer’s dis­ease: A Reg­u­la­to­ry Per­spec­tive (The Jour­nal of Pre­ven­tion of Alzheimer’s Dis­ease): –This arti­cle is adapt­ed from a com­pre­hen­sive con­ver­sa­tion between Dr. Murali Doraiswamy and Dr. Jef­frey Shuren at the 2021 Clin­i­cal Tri­als on Alzheimer’s Dis­ease (CTAD) con­fer­ence in Boston. Dr. Shuren is a behav­ioral neu­rol­o­gist who has held a variety…

Read More

Update on the aducanumab (Aduhelm) saga, retirement, financial advice, cognitive health, excessive worrying, neurotech, and more

By SharpBrains | June 30, 2021

Wel­come to a new edi­tion of Sharp­Brains’ e‑newsletter, pro­vid­ing this time a sum­ma­ry of the saga around the FDA approval of adu­canum­ab (Aduhelm) as a sup­posed treat­ment for Alzheimer’s Dis­ease, plus a range of time­ly research find­ings and resources for life­long brain health. First, below are some key reads to nav­i­gate “prob­a­bly the worst drug approval…

Read More

On building better brains at any age, treating Depression vs. Dementia, emerging neurotechnologies, psychedelics, and more

By SharpBrains | May 28, 2021

Wel­come to a new edi­tion of Sharp­Brains’ e‑newsletter, fea­tur­ing eleven new research find­ings and inno­v­a­tive resources for life­long cog­ni­tive and brain health. #1. Debate: Are depres­sion and demen­tia two sides of the same coin? And, if they are, how to best approach treat­ment? #2. Either way, the ear­li­er the bet­ter, but it’s nev­er too late: New…

Read More